5-Fluorouracil plus interferon α-2a compared to 5-fluorouracil alone in the treatment of advanced colon carcinoma: A multicentric randomized study

Journal of Cancer Research and Clinical Oncology

Volumn 124, Issue 3-4, 1998, Pages 191-198

  Palmeri, S ^a   Meli, M ^a   Danova, M ^b   Bernardo, G ^c   Leonardi, V ^a   Dastoli, G ^d   Rausa, L ^a   Russo, A ^a,a,g,g   Filippelli, G ^e   Palmieri, G ^f   Della Vittoria Scarpati, M ^f   Lo Russo, V ^h   Di Lauro, L ⁱ   Colucci, G ^h   Bruni, G ^j   Piazzi, M ^k   Gebbia, N ^a   Spada, S ^l  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c IRCCS   (Italy)

^d ROCHE MILANO RICERCHE   (Italy)

^e Osp Civ Annunziata   (Italy)

^f UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^g CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^h NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

ⁱ REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^j NATIONAL CANCER INSTITUTE   (Italy)

^k BELLARIA HOSPITAL   (Italy)

^l Civic Hospital   (Italy)

more..

Author keywords

5 fluorouracil; Advanced colon cancer; Biochemical modulation; Immunotherapy; Interferon 2a

Indexed keywords

ALPHA2A INTERFERON; FLUOROURACIL;

ADULT; AGED; ARTICLE; BONE METASTASIS; CLINICAL TRIAL; COLON CARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LIVER METASTASIS; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NAUSEA; PERITONEUM METASTASIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL TIME; VOMITING;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLONIC NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; INTERFERON ALFA-2A; MALE; MIDDLE AGED;

EID: 15144344797     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050154     Document Type: Article

References (50)

1. Bobbio Pallavicini E, Porta C, Moroni M, Spaghi A, Casagranda I, Nastasi G (1993) Folinic acid improve 5-fluorouracil activity in vivo. Results of a phase III study comparing 5-fluorouracil to 5-fluorouracil and folinic acid in advanced colon cancer patients. J Chemother 5:52-55
2. Buroker TR, Moertel CG, Fleming TR, Everson LK, Cullinan SA, Krook JE et al. (1985) A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinoma. J Clin Oncol 3:1624-1631
3. Cellerino R, Antognoli S, Giustini E, Acito L, Marcellini M, Bavosi M, Trivisonne R, Francini G, Del Papa M, Rossi G (1994) A randomized study of fluorouracil (5FU) with or without alpha-interferon (IFN) in advanced colorectal cancer. Proc ASCO 13:A654
4. Chu E, Zinn S, Boarman D, Allegra CJ (1990) Interaction of interferon and 5-fluorouracil in the H630 human colon carcinoma cell line. Cancer Res 50:5834-5840
5. Chu E, Voeller DM, Johnston PG, Allegra CJ (1993) Regulation of thymidylate synthase in human colon cancer cells treated with 5-fluorouracil and interferon-gamma. Mol Pharmacol 43:527-533
6. Danhauser LL, Freimann JH, Gilchrist TL, Gutterman JU, Hunter CY, Yeomans AC, Markowitz AB (1993) Phase I and pharmacokinetic study of infusional fluorouracil combined with recombinant interferon alpha-2b in patients with advanced cancer. J Clin Oncol 11:751-761
7. Di Costanzo F, Bartolucci R, Sofra M (1989) 5-Fluorouracil alone versus high dose folinic acid and 5-FU in advanced colorectal cancer. A randomized trial of the Italian Oncology Group for Clinical Research. Proc ASCO 8:109
8. Di Costanzo F, Bartolucci R, Piccinini L, Sabbatini R, Leonardi F, Corgna E, Figoli F, Passalacqua R, Algeri R, Finardi C (1992) High dose folinic acid (FA) and 5FU alone or combined with hydroxyurea (HU) in advanced colorectal cancer (CRC): a randomized trial of the Italian Oncology Group for Clinical Research (GOIRC). Ann Oncol 3 [Suppl 5]:190
9. Doroshow JH, Multhauf P, Leong L, Margolin K, Litchlield T, Akamn S (1990) Prospective randomized comparison of fluorouracil versus fluorouracil and high dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancers in patients previously unexposed to chemotherapy. J Clin Oncol 8:491-501
10. Dufour P, Husseini F, Dreyfus B, Cure H, Martin C, Prevost G, Olivier JP, Dumas F, Duclos B, Olivares R, Leszler A, Bergerat JP, Adhuy B, Thill L, Oberling F (1996) 5-Fluorouracil versus 5-fluorouracil plus α-interferon as treatment of metastatic colorectal carcinoma. A randomized study. Ann Oncol 7:575-579
11. Elias L, Crissman HA (1988) Interferon effects upon the adenocarcinoma 38 and HL-60 cell lines: antiproliferative responses and synergistic interactions with halogenated pyrimidine antimetabolites. Cancer Res 48:4861-4873
12. Elias L, Sandoval JM (1989) Interferon effects upon fluorouracil metabolism by HL-60 cells. Biochem Biophys Res Commun 163:867-874
13. Erlichman C, Fine S, Wong A, Elhakim T (1988) A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma. J Clin Oncol 6:469-475
14. Evans RM, Laskin GD, Hakala MT (1981) Effect of excess of folate and deoxyinosine on the activity and site of action of 5-fluorouracil. Cancer Res 41:3288-3295
15. Fornasiero A, Daniele O, Ghiotto C, Aversa SM, Morandi P, Fiorentino MV (1990) Alpha-2 interferon and 5-fluorouracil in advanced colorectal cancer. Tumori 76:385-388
16. Gewert DR, Moore G, Clemens MJ (1983) Inhibition of cell division by interferons. The relationship between changes in utilization of thymidine for DNA synthesis and control of proliferation in Daudi cells. Biochem J 214:983-990
17. Greco FA, Figlin R, York M, Einhorn L, Schilsky R, Marshall EM, Buys SS, Fraimtchuk MJ, Schuller J, Schuchter L, Buyse M, Ritter L, Man A, Yap AKL (1996) Phase III randomized study to compare interferon alpha-2a in combination with fluorouracil versus fluorouracil alone in patients with advanced colorectal cancer. J Clin Oncol 14:2674-2681
18. Hermann R, Knutt A, Kleeberg U, et al. (1986) Randomized multicenter trial of sequential methotrexate and 5-fluorouracil (5-FU) vs 5-FU alone in metastatic colorectal carcinoma. Proc ASCO 5:91
19. Hill M, Norman A, Cunningham D, Findlay M, Nicolson V, Hill A, Iveson A, Evans C, Joffe J, Nicolson M, Hickish T (1995) Royal Marsden Phase III trial of fluorouracil with or without interferon alpha-2b in advanced colorectal cancer. J Clin Oncol 13:1297-1302
20. Huberman M, Bering H, Tessitore J, Groopman J, Tran L, Young D, Evans L (1990) 5-Fluorouracil (5FU) plus recombinant alpha-interferon (Roferon A) in advanced colorectal cancer. Proc ASCO 9:A116
21. Kemeny N, Younes A (1992) Alfa-2A interferon and 5-fluorouracil for advanced colorectal carcinoma: the Memorial Sloan-Kettering experience. Semin Oncol 19:171-175
22. Labianca R, Pancera G, Cesana B, Clerici M, Montinari F, Luporini G (1988) Cisplatin + 5-fluorouracil versus 5-fluorouracil alone in advanced colorectal cancer: a randomized study. Eur J Cancer Clin Oncol 24:1579-1581
23. Labianca R, Pancera G, Aitini E, Barni S, Beretta A, Beretta GD (1991) Folinic acid + 5-fluorouracil (5FU) versus equidose 5FU in advanced colorectal cancer: phase III study of GISCAD (Italian Group for Study of Digestive Tract Cancer). Ann Oncol 2:673-679
24. Laufman L, Bukowski R, Collier M, Sullivan B, McKinnis R, Clendennin N, Guaspari A, Brenkman W (1993) A randomized, double-blind trial of fluorouracil plus placebo versus fluorouracil plus oral leucovorin in patients with metastatic colorectal cancer. J Clin Oncol 11:1888-1893
25. Leichman CG, Fleming TR, Muggia FM, Tangen CM, Ardalan B, Doroshow JH, Meyers FJ, Holcombe RF, Weiss GR, Mangalik A, Macdonald JS (1995) Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study. J Clin Oncol 13:1303-1311
26. Loehrer PJ, Turner S, Kubilis P, Hui S, Correa J, Ansari R, Stephens D, Woodburn R, Meyer S (1988) A prospective randomized trial of fluorouracil versus fluorouracil plus cisplatin in the treatment of metastatic colorectal cancer: a Hoosier Oncology Group trial. J Clin Oncol 6:642-648
27. Loffler T, Korsten FW, Burghard F (1989) Randomized comparison of 5-FU vs. 5-FU/medium dose leucovorin in metastatic colorectal cancer. Eur Conf Clin Oncol O-0628
28. Madajewicz S, Avvento L (1990) Clinical trials with 5-fluorouracil, folinic acid and cisplatin in patients with gastrointestinal malignancies. J Chemother 2 [Suppl 1]:33-37
29. Martoni A, Cricca A, Guaraldi M, Covizzi M, Farris A, Pannuti F (1992) Weekly regimen of 5FU vs 5FU + intermediate dose folinic acid in the treatment of advanced colorectal cancer. Anticancer Res 12:607-612
30. Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47:207-214
31. Miyoshi T, Ogawa S, Kanamori T, et al. (1983) Interferon potentiates cytotoxic effects of 5-fluorouracil on cell proliferation of established human cell lines originated from neoplastic tissues. Cancer Lett 17:239-247
32. Neefe JR, Sigals R, Ayoob M, Schein PS (1984) Minimal activity of recombinant clone A interferon in metastatic colon cancer. J Biol Response Mod 3:366-370
33. Nobile MT, Canobbio L, Sobrero A, Galligioni E, Vidili MG, Fassio T (1988) A randomized trial of 5-fluorouracil and high dose leucovorin in untreated advanced colorectal cancer patients. Adv Exp Med Biol 244:213-218
34. Palmeri S, Gebbia V (1991) Combined 5-fluorouracil and recombinant alpha-2A interferon vs. 5-fluorouracil alone in metastatic colorectal carcinoma: a multicenter randomized study. J Surg Oncol Suppl 2:134-136
35. Palmeri S, Gebbia V, Rausa L (1990) 5-Fluorouracil and recombinant alpha-interferon-2a in the treatment of advanced colorectal carcinoma: a dose-optimization study. J Chemother 2:327-330
36. Petrelli N, Douglass HO, Herrera L, Russell D, Stablein DM, Bruckner HW (1989) The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. J Clin Oncol 7:1419-1426
37. Petrelli N, Herrera L, Rustum Y, Burke P, Creaven P, Stule J (1987) A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma. J Clin Oncol 5:1559-1565
38. Pfeffer LM, Tamm I (1984) Interferon inhibition of thymidine incorporation into DNA through effects on thymidine transport and uptake. J Cell Physiol 121:431-436
39. Poon MA, O'Connell MJ, Moertel CG, Wieand HS, Cullinan SA, Everson LK, Crook JE, Maillard JA, Laurie JA, Tschetter LK, Wiessenfeld M (1989) Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. J Clin Oncol 7:1407-1411
40. Raderer M, Scheithauer W (1995) Treatment of advanced colorectal cancer with 5-fluorouracil and interferon-α: an overview of clinical trials. Eur J Cancer 31:1002-1008
41. Schwartz EL, Hoffman M, O'Connor CJ, Wadler S (1992) Stimulation of 5-fluorouracil metabolic activation by interferon-a in human colon carcinoma cells. Biochem Biophys Res Commun 182:1232-1239
42. The Nordic Gastrointestinal Tumor Adjuvant Therapy Group (1989) Superiority of sequential methotrexate, fluorouracil, and leucovorin to fluorouracil alone in advanced symptomatic colorectal carcinoma: a randomized trial. J Clin Oncol 7:1437-1446
43. Ulmann B, Lee M, Martin DW, Santi DW (1978) Cytotoxicity of 5-fluoro-2′deoxyuridylate: requirement for reduced folate cofactors and antagonism by methotrexate. Proc Natl Acad Sci USA 75:980-983
44. Valone FH, Friedman MA, Wittlinger PS, Drakes T, Eisenberg PD, Malec M, Hannigan JF, Brown BW (1989) Treatment of patients with advanced colorectal carcinoma with fluorouracil alone, high dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group. J Clin Oncol 7:1427-1436
45. Wadler S, Schwartz EL, Goldman M, Lyver A, Rader M, Zimmerman M, Itri L, Weinberg V, Wiernik PH (1989) Fluorouracil and recombinant α-2a-interferon: an active regimen against advanced colorectal carcinoma. J Clin Oncol 7:1769-1775
46. Wadler S, Wersto R, Weinberg V, Thompson D, Schwartz EL (1990) Interaction of fluorouracil and interferon in human colon cancer cell lines: cytotoxic and cytokinetic effects. Cancer Res 50:5735-5739
47. Wadler S, Lambersky B, Atkins M, Kirkwood J, Petrelli N (1991) Phase II trial of fluorouracil and recombinant interferon alpha-2a in patients with advanced colorectal carcinoma: an Eastern Cooperative Oncology, Group Study. J Clin Oncol 9:1806-1810
48. Waxman S, Bruckner H (1982) Enhancement of 5-fluorouracil antimetabolic activity by leucovorin, menadione and α-tocopherol. Eur J Cancer Clin Oncol 18:685-692
49. Weh HJ, Platz D, Braumann D, Buggisch P, Schmiegel WH, Drescher S (1992) Treatment of metastatic colorectal carcinoma with a combination of fluorouracil and recombinant interferon alpha-2b: preliminary data of a phase II study. Semin Oncol 19 [Suppl 2]:180-184
50. Yee LK, Allegra CJ, Steinberg SM, Grem JL (1992) Decreased catabolism of 5-fluorouracil in peripheral blood mononuclear cells during therapy with 5-fluorouracil, leucovorin and interferon α-2a. J Natl Cancer Inst 84:1820-1825